current levels, and BMO Capital is the latest research house to lower its rating on the stock to underperform from market perform. Cronos shares were down 4% in trading Monday, but other pot stocks as a whole are holding up against the negative analyst note. is up 1% after dipping into the red following the note, while Aurora Cannabis is up more than 2%.